Jin Medical International Ltd. (ZJYL)

Jin Medical International Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Year	2023	2022	2021
Cash & Equivalents	6.93	4.79	3.67
Short-Term Investments	9.77	2.28	2.05
Cash & Cash Equivalents	16.7	7.07	5.73
Cash Growth	136.23%	23.44%	-
Receivables	8.47	4.12	5.27
Inventory	5.05	6.72	6.89
Other Current Assets	0.89	0.99	1.53
Total Current Assets	31.12	18.9	19.42
Property, Plant & Equipment	1.48	1.63	2.11
Goodwill and Intangibles	0.15	0.16	0.19
Other Long-Term Assets	0.15	0.25	0.18
Total Long-Term Assets	1.79	2.04	2.48
Total Assets	32.9	20.94	21.9
Accounts Payable	3.39	4.23	5.36
Deferred Revenue	0.83	0.83	1.68
Current Debt	4.11	0	0
Other Current Liabilities	0.59	0.64	0.83
Total Current Liabilities	8.92	5.7	7.87
Total Liabilities	8.92	5.7	7.87
Total Debt	4.11	0	0
Retained Earnings	16.93	14.41	11.89
Comprehensive Income	-1.4	-0.91	0.59
Shareholders' Equity	23.98	15.24	14.03
Net Cash / Debt	12.59	7.07	5.73
Net Cash / Debt Growth	78.04%	23.44%	-
Net Cash Per Share	0.09	0.05	0.04
Working Capital	22.19	13.2	11.55
Book Value Per Share	0.17	0.11	0.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).